Riskpilot← Back to searchSign inGet full accessApoteket Gode Herden AB
ABActiveOrg 5568502453Hovslagarvägen 24Retail sale of pharmaceutical products · NACE 4773Est. 20116 employees
Revenue 2024
SEK 37M
+13% vs 2023
EBITDA margin
3.3%
+42% vs 2023
Equity ratio
36.4%
Financial strength
Net profit 2024
SEK 848K
+2% vs 2023
| Revenue | SEK 37M | +13% |
| EBITDA | SEK 1,2M | +42% |
| Net profit | SEK 848K | +2% |
| Total assets | SEK 10,7M | +13% |
| Equity | SEK 3,9M | +10% |
| Employees | 6 | — |
Legal name
Apoteket Gode Herden AB
Org number
5568502453
Legal form
Aktiebolag
NACE code
4773 · Retail sale of pharmaceutical products
Founded
20 april 2011
Share capital
SEK 50 000
Employees
6 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget ska bedriva apotekshandel, äga och förvalta värdepapper samt därmed förenlig verksamhet.
Address
Hovslagarvägen 24
Phone
+46855099106
Email
samir.sanharib@apoteketgodeherden.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 27 659 | 28 495 | 29 484 | 32 650 | 37 005 |
| Staff expenses | — | — | −3 415 | −3 719 | −3 891 |
| EBITDA | 1 168 | 409 | 652 | 856 | 1 214 |
| Depreciation & amort. | −61 | −30 | −29 | −29 | −29 |
| EBIT | 1 107 | 379 | 623 | 827 | 1 184 |
| Net financials | −24 | −15 | −12 | 16 | 16 |
| Profit before tax | 823 | 627 | 617 | 1 058 | 1 081 |
| Tax | −180 | −136 | −131 | −228 | −233 |
| Net profit | 643 | 491 | 486 | 830 | 848 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 7 949 | 8 554 | 9 055 | 9 494 | 10 705 |
| Equity | 2 145 | 2 636 | 3 122 | 3 552 | 3 900 |
| Long-term debt | 2 083 | 1 759 | 1 778 | 1 761 | 2 004 |
| Short-term debt | 2 455 | 3 157 | 3 160 | 3 401 | 3 901 |
| Total debt | 4 538 | 4 916 | 4 938 | 5 162 | 5 905 |
EBITDA margin
3.3%
This company
15.8%
Market median
-79% vs market
20202024
Equity ratio
36.4%
This company
38.2%
Market median
+5% vs market
20202024
Return on equity
21.7%
This company
18.4%
Market median
+18% vs market
20202024
Net profit margin
2.3%
This company
8.1%
Market median
-72% vs market
20202024
Asset turnover
3.46×
This company
1.12×
Market median
+209% vs market
20202024
Debt / equity
1.74×
This company
0.62×
Market median
-181% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KR | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Apoteket Gode Herden AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kent Robert Valdemar Malmer | Audit | 0 companies |
| Metti Sanharib | Deputy Board Member | 0 companies |
| Samir Sanharib | Board of Directors | 0 companies |